Caregen Co., Ltd. (KOSDAQ:214370)
South Korea
· Delayed Price · Currency is KRW 72,900
-800 (-1.09%)
At close: Dec 5, 2025
Caregen Revenue
Caregen had revenue of 17.09B KRW in the quarter ending September 30, 2025, a decrease of -15.89%. This brings the company's revenue in the last twelve months to 77.86B, down -1.03% year-over-year. In the year 2024, Caregen had annual revenue of 82.59B with 4.26% growth.
Revenue (ttm)
77.86B
Revenue Growth
-1.03%
P/S Ratio
45.76
Revenue / Employee
403.40M
Employees
193
Market Cap
3,562.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82.59B | 3.38B | 4.26% |
| Dec 31, 2023 | 79.21B | 10.11B | 14.63% |
| Dec 31, 2022 | 69.10B | 10.01B | 16.94% |
| Dec 31, 2021 | 59.09B | -1.21B | -2.00% |
| Dec 31, 2020 | 60.30B | -4.40B | -6.81% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |
| KB Financial Group | 14.89T |
Caregen News
- 1 year ago - Akums Drugs shares surge 5% after signing Master Sales Agreement with Caregen - Business Upturn
- 1 year ago - Akums Drugs signs Master Sales Agreement with Caregen for Indian Nutraceutical market expansion - Business Upturn